ImmunityBio, Inc. (NASDAQ:IBRX) is one of the stocks mentioned during the show, as we cover everything Jim Cramer said about the oversold market. When a caller inquired about the stock during the lightning round, Cramer said:
ImmunityBio had a big cross of a huge amount of stock, but at the end, I don’t know where that stock went to. I’d like to see the stock come in and see if that block holds before I buy that because that stock is part of the magical thinking era.
A stock market graph. Photo by energepic.com
ImmunityBio, Inc. (NASDAQ:IBRX) develops therapies designed to strengthen the immune system against infectious diseases and several cancers. A caller inquired about the stock during the January 20 episode, and Cramer responded:
Okay, now that… see what happens, I think is you already had that. That moved gigantically. It’s had a giant run off this FDA meeting, and I really think that you have to take profits in some of that, not all of it, but some of it, because it’s up so big.
While we acknowledge the potential of IBRX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years
Disclosure: None. Follow Insider Monkey on Google News.
